The virtual phantom technology embodied in VirtualDose™CT has received considerable attention throughout the health radiation industry. The beta test wrapping up this spring under a major grant from the National Institutes of Health has given top health physicists and radiology directors at major U.S. hospitals the opportunity to work directly with the technology. Their reactions have been extremely positive. We are incorporating their recommendations into the product. We will release more information about the beta test results later this year.

We welcome press inquiries. Please send to or contact our Chief Operations Officer, John Crossin at (978) 549-3868.